Sectors

AUPH
Aurinia Pharmaceuticals Inc.
15.38
6 x 15.40
1 x 15.45
bid
ask
-
0.26
1.66%
10:02 AM
timesize
Ytd-3.57%
1y73.20%
15.44
day range
15.65
8.88
52 week range
18.62
Open15.56Prev Close15.64Low15.44High15.65Mkt Cap2.01B
Vol62.53KAvg Vol1.50MEPS0.90P/E17.38Forward P/E18.48
Beta1.41Short Ratio5.19Inst. Own60.33%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg16.01200-d Avg15.001yr Est17.00

AUPH News

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
gurufocus.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Beli

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, m

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
businesswire.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Beli

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) tod

Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
zacks.com
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why

Aurinia (AUPH) might move higher on growing optimism about its earnings prospects, which is reflecte

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
zacks.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

5 Small Drug Stocks to Invest in Amid a Biotech Comeback
zacks.com
5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
zacks.com
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?

Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than averag

Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
fool.com
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

814,606 common shares acquired for a total transaction value of approximately $12.5 million, based o

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow
seekingalpha.com
Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow

Aurinia Pharmaceuticals (AUPH) is positioned for profitable growth, driven by Lupkynis and pipeline

LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
businesswire.com
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--LUPKYNIS Associated with a Statistically Signif

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
feeds.newsfilecorp.com
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences

Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratu

Parabolic AI rally has bulls eyeing a comeback for this one-time meme metal trade
cnbc.com
Parabolic AI rally has bulls eyeing a comeback for this one-time meme metal trade

Silver prices surged 7% Monday to the highest since March.

Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates
zacks.com
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.25 per share, beating the Zack

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress
businesswire.com
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Prov

ROCKVILLE, Maryland & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Reports Financial

Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison
defenseworld.net
Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison

Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and Cronos Group (NASDAQ: CRON - Get Free R

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of “Hold” by Analysts
defenseworld.net
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of “Hold” by Analysts

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH - Get Free Report) (TSE: AUP) has earned an average recomm

SG Americas Securities LLC Grows Position in Aurinia Pharmaceuticals Inc $AUPH
defenseworld.net
SG Americas Securities LLC Grows Position in Aurinia Pharmaceuticals Inc $AUPH

SG Americas Securities LLC raised its holdings in Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) (TSE: A

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
businesswire.com
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingen

ROCKVILLE, Maryland & EDMONTON, Alberta & SOUTH SAN FRANCISCO, California--(BUSINESS WIRE)--Aurinia

Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance
seekingalpha.com
Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance

Aurinia Pharmaceuticals has undergone a major management overhaul, with fund manager and activist in

MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition
businesswire.com
MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition

CAYMAN ISLANDS--(BUSINESS WIRE)--MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “w

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For July 31, 2025

benzinga.com
Earnings Scheduled For May 12, 2025

benzinga.com
Earnings Scheduled For February 27, 2025

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 250 stocks hit new 52-week lows.